A Singular Vision

Singular Vision

Relentless pursuit of transformative therapies targeting FcRn, a central mediator in autoimmune responses.

Focused Execution

Focused Execution

Rapid clinical advancement across multiple indications for our lead investigational candidate SYNT001.

Vast Reach

Vast Reach

FcRn plays a central role across a wide swath of autoimmune diseases affecting millions of people worldwide.

NEWS & PROGRESS

NOVEMBER 2, 2018

Alexion Completes Acquisition Of Syntimmune

LATEST TWEET

@syntimmune | SEPTEMBER 21, 2018

Our scientists played pivotal roles in advancing understanding of the complex role of FcRn in IgG-mediated autoimmu… https://t.co/MsuJR9LzYf